Click Here to
News, Updates,
& More
Stay Up
to Date

Original Research

Ovarian cancer is the leading cause of death among gynecologic tumors.
Pharmacists play a vital role in ensuring the safe administration of medications.
Nathan M. Kawamura, PharmD, BCOP, and colleagues assess the reasons for dose reductions and treatment discontinuation in patients who receive oral chemotherapy for metastatic kidney cancer.

This single-institution study led by Caroline Townley, PharmD, compares the use of the Onpro device and the manual injection of pegfilgrastim and discusses the potential implications of the findings.

Ákos Juhász, PharmD, and colleagues suggest that the use of a closed-system drug-transfer device would reduce the high levels of contamination found in hospital pharmacies.

In their study, Mark L. Zangardi, PharmD, BCOP, and colleagues, demonstrate that clinical pharmacists have an integral role in the review and approval of off-label oncology treatments.

This pilot study demonstrated that pharmacists in an ambulatory oncology clinic are able to deliver successful tobacco-cessation counseling and interventions for patients with cancer who smoke.

The World Health Organization’s pain ladder for cancer recommends opioids for the treatment of moderate-to-severe pain in patients with cancer, and is a mainstay of cancer pain therapy.

Drug containers are defined in USP 797 based on the type of the container and the environment in which the container is opened. Vials are further divided into 2 categories: single-dose or multiple-dose.

Oral chemotherapeutic agents have been available for many years, and were traditionally cytotoxic drugs, such as cyclophosphamide, methotrexate, and mercaptopurine. In recent years, oral anticancer medications are being used more often in many types of cancer.
Page 2 of 6
Results 11 - 20 of 58